Immunohistochemical staining, particularly with markers such as HSP70, glypican-3 (GPC3), and glutamine synthetase (GS), provides additional diagnostic specificity, with positivity for at least two markers strongly supporting the diagnosis of hepatocellular carcinoma. The gene discussed is GLUL; the disease is hepatocellular carcinoma.